Drug Safety and Risk Management Advisory Committee Notice of Meeting
Document ID: FDA-2012-N-0548-0086
Comments
Total: 399
-
Judith Diane Ferguson - Comment
Posted : 01/03/2013 ID :FDA-2012-N-0548-0087 Agency : FDA -
Jan 09,2013 11:59 PM ET
-
Tamara Ann Hull - Comment
Posted : 01/03/2013 ID :FDA-2012-N-0548-0088 Agency : FDA -
Jan 09,2013 11:59 PM ET
-
Advocates for the Reform of Prescription Opioids, Inc. (ARPO) - Comment
Posted : 01/03/2013 ID :FDA-2012-N-0548-0089 Agency : FDA -
Jan 09,2013 11:59 PM ET
-
elise kaplan - Comment
Posted : 01/04/2013 ID :FDA-2012-N-0548-0090 Agency : FDA -
Jan 09,2013 11:59 PM ET
-
ken b cairns - Comment
Posted : 01/04/2013 ID :FDA-2012-N-0548-0091 Agency : FDA -
Jan 09,2013 11:59 PM ET
-
Daniel Paulson - Comment
Posted : 01/04/2013 ID :FDA-2012-N-0548-0092 Agency : FDA -
Jan 09,2013 11:59 PM ET
-
ken b cairns - Comment
Posted : 01/04/2013 ID :FDA-2012-N-0548-0093 Agency : FDA -
Jan 09,2013 11:59 PM ET
-
Mark Terry Sokolow - Comment
Posted : 01/07/2013 ID :FDA-2012-N-0548-0094 Agency : FDA -
Jan 09,2013 11:59 PM ET
-
Jamie Cameron - Comment
Posted : 01/14/2013 ID :FDA-2012-N-0548-0095 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Sarah McNeal - Comment
Posted : 01/14/2013 ID :FDA-2012-N-0548-0096 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Daniel A. Busch, M.D. - Comment
Posted : 01/14/2013 ID :FDA-2012-N-0548-0097 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Natalie Alison Hayes - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0098 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Melissa Anderson - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0099 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
American Academy of Pain Medicine - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0100 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Sue R Hollar - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0101 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Cynthia Lee - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0102 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Cynthia Louise Hughes - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0103 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Geri D Weitzman PhD - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0104 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Drug Watch International, Inc. - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0105 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Paula Jane Sanders - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0106 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Gloria - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0107 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Anonymous - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0108 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Thomas William Almond - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0109 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Thomas William Almind - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0110 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Michael Rader - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0111 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Lisa Ferrell - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0112 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
James Quintus Putnam - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0113 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
David Lewis - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0114 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Cathleen Orr - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0115 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Rebecca A Kirch - Comment
Posted : 02/01/2013 ID :FDA-2012-N-0548-0116 Agency : FDA -
Feb 01,2013 11:59 PM ET